Advertisement|Remove ads.

Lucid Motors (LCID) on Friday celebrated a major milestone in its autonomous vehicle push, announcing that one of its executives took their first Lucid-Nuro robotaxi ride, providing public confirmation that the partnership has moved into real-world testing.
“Just took my first ride in a Lucid × Nuro × Uber robotaxi. Only nine months after announcing the partnership, it was impressive to experience how natural it already feels,” Lucid’s head of communications Nick Twork said.
Twork said the ride felt seamless and represented “a big milestone for the teams involved and an exciting glimpse at what’s ahead.” The post included an image from inside the vehicle during the test ride and shows a human in both front seats, implying that the company has yet to conduct real-world testing without a driver to take over as needed.
Uber Technologies, Lucid Group, and Nuro announced a strategic partnership in July 2025 to launch a premium global robotaxi program exclusively on the Uber ride-hailing platform.
The agreement was significantly expanded in April 2026, with Uber now committing to deploy at least 35,000 Lucid vehicles—including Gravity electric SUVs and models from the EV maker’s upcoming midsize platform—equipped with Nuro’s “Nuro Driver” autonomy system over six years across dozens of markets worldwide. These vehicles would be owned and operated by Uber or its third-party fleet partners. The collaboration aims to combine Lucid’s luxury vehicles with Nuro’s self-driving technology and Uber’s scale.
Commercial deployment is scheduled to begin in a major U.S. city, starting in the San Francisco Bay Area, later in 2026.
Lucid has positioned robotaxi development as a key growth driver as it seeks to move beyond low-volume luxury EV sales and generate new revenue streams in the emerging autonomous mobility market.
Earlier this week, Lucid executive Marc Winterhoff told the audience at the Financial Times “Future of the Car 2026” summit that the three-company agreement “is not limited to the U.S.”
“There are plans, which I cannot go into detail right now, but there are plans to go into other markets as well,” Winterhoff said. “Europe and certain countries in Europe are high on the list. That’s definitely on the roadmap.”
He added that the partners are already preparing together, though the timeline will depend on regulatory approvals and certifications in each market. “The teams are working on that,” he said.
On Stocktwits, retail sentiment around LCID stayed within the ‘bearish’ territory at the time of writing, coupled with ‘low’ retail chatter.
LCID stock has fallen 78% over the past 12 months.
Read More: CADL Stock Edges Up After Hours On Strong Extended Prostate Cancer Data
For updates and corrections, email newsroom[at]stocktwits[dot]com.